FDA Unveils Medical Device “Postmarket Transformation”
This article was originally published in The Gray Sheet
Executive Summary
FDA's device center is establishing a senior-level team of agency staffers and outside experts to lead an effort to revitalize the postmarket device safety program, the agency announced Jan. 19